1.Alirocumab for the treatment of hypercholesterolemia

Tomlinson, B, Hu, M,     More...

Tomlinson, B, Hu, M, Zhang, YZ, Chan, P, Liu, ZM     Less

EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2017, Volume 17, Issue 5, Pages 633-643

收錄情况： WOS SCOPUS

WOS核心合集引用: 23  2023影響因子:  3.6  发表年影響因子:  3.974 

2.Evolocumab for the treatment of hypercholesterolemia

Tomlinson, B, Hu, M,     More...

Tomlinson, B, Hu, M, Zhang, YZ, Chan, P, Liu, ZM     Less

EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2017, Volume 17, Issue 11, Pages 1447-1461

收錄情况： WOS SCOPUS

WOS核心合集引用: 8  2023影響因子:  3.6  发表年影響因子:  3.974 

3.An up-to-date review of emerging biologic therapies for hypercholesterolemia

Tomlinson, B     More...

Tomlinson, B     Less

EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2023影響因子:  3.6